Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Pathogenesis of chronic obstructive pulmonary disease
Rubin M. Tuder, Irina Petrache
Rubin M. Tuder, Irina Petrache
Published August 1, 2012
Citation Information: J Clin Invest. 2012;122(8):2749-2755. https://doi.org/10.1172/JCI60324.
View: Text | PDF | Corrigendum
Review Series Article has an altmetric score of 4

Pathogenesis of chronic obstructive pulmonary disease

  • Text
  • PDF
Abstract

The current epidemic of chronic obstructive pulmonary disease (COPD) has produced a worldwide health care burden, approaching that imposed by transmittable infectious diseases. COPD is a multidimensional disease, with varied intermediate and clinical phenotypes. This Review discusses the pathogenesis of COPD, with particular focus on emphysema, based on the concept that pulmonary injury involves stages of initiation (by exposure to cigarette smoke, pollutants, and infectious agents), progression, and consolidation. Tissue damage entails complex interactions among oxidative stress, inflammation, extracellular matrix proteolysis, and apoptotic and autophagic cell death. Lung damage by cigarette smoke ultimately leads to self-propagating processes, resulting in macromolecular and structural alterations — features similar to those seen in aging.

Authors

Rubin M. Tuder, Irina Petrache

×

Total citations by year

Year: 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 Total
Citations: 5 16 12 12 28 26 21 22 23 18 20 17 11 2 233
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article in year 2016 (18)

Title and authors Publication Year
Fibulin-1 regulates the pathogenesis of tissue remodeling in respiratory diseases
Gang Liu, Marion Cooley, andrew Jarnicki, Alan Hsu, Prema Nair, Tatt Jhong Haw, Michael Fricker, Shaan Gellatly, Richard Kim, Mark Inman, Gavin Tjin, Peter Wark, Marjorie Walker, Jay Horvat, Brian Oliver, W Scott Argraves, Darryl Knight, Janette Burgess, Philip Hansbro
JCI Insight 2016
Structural and functional characterization of endothelial microparticles released by cigarette smoke
KA Serban, S Rezania, DN Petrusca, C Poirier, D Cao, MJ Justice, M Patel, I Tsvetkova, K Kamocki, A Mikosz, KS Schweitzer, S Jacobson, A Cardoso, N Carlesso, WC Hubbard, K Kechris, B Dragnea, EV Berdyshev, J McClintock, I Petrache
Scientific Reports 2016
Alpha-1 Antitrypsin Investigations Using Animal Models of Emphysema
K Ni, KA Serban, C Batra, I Petrache
Annals of the American Thoracic Society 2016
Treatment with intranasal iloprost reduces disease manifestations in a murine model of previously established COPD
MR Lammi, MA Ghonim, K Pyakurel, AS Naura, SV Ibba, CJ Davis, SC Okpechi, KI Happel, BP deBoisblanc, J Shellito, AH Boulares
American journal of physiology. Lung cellular and molecular physiology 2016
Bax-induced apoptosis shortens the life span of DNA repair defect Ku70-knockout mice by inducing emphysema
S Matsuyama, J Palmer, A Bates, I Poventud-Fuentes, K Wong, J Ngo, M Matsuyama
Experimental biology and medicine (Maywood, N.J.) 2016
Differential Effects of p38, MAPK, PI3K or Rho Kinase Inhibitors on Bacterial Phagocytosis and Efferocytosis by Macrophages in COPD
MA Bewley, KB Belchamber, KK Chana, RC Budd, G Donaldson, JA Wedzicha, CE Brightling, I Kilty, LE Donnelly, PJ Barnes, D Singh, MK Whyte, DH Dockrell, UA Maus
PloS one 2016
Airway bacteria drive a progressive COPD-like phenotype in mice with polymeric immunoglobulin receptor deficiency
BW Richmond, RM Brucker, W Han, RH Du, Y Zhang, DS Cheng, L Gleaves, R Abdolrasulnia, D Polosukhina, PE Clark, SR Bordenstein, TS Blackwell, VV Polosukhin
Nature Communications 2016
The Mucus Barrier to Inhaled Gene Therapy
GA Duncan, J Jung, J Hanes, JS Suk
Molecular Therapy 2016
Hhip haploinsufficiency sensitizes mice to age-related emphysema
T Lao, Z Jiang, J Yun, W Qiu, F Guo, C Huang, JD Mancini, K Gupta, ME Laucho-Contreras, ZZ Naing, L Zhang, MA Perrella, CA Owen, EK Silverman, X Zhou
Proceedings of the National Academy of Sciences 2016
Lost in Trans-IL-6 Signaling: Alveolar Type II Cell Death in Emphysema
I Petrache, K Serban
American journal of respiratory and critical care medicine 2016
Association of MicroRNA-196a2 Variant with Response to Short-Acting β2-Agonist in COPD: An Egyptian Pilot Study
MS Fawzy, MH Hussein, EZ Abdelaziz, HA Yamany, HM Ismail, EA Toraih, XY Guan
PloS one 2016
Epithelial Notch signaling regulates lung alveolar morphogenesis and airway epithelial integrity
PN Tsao, C Matsuoka, SC Wei, A Sato, S Sato, K Hasegawa, H Chen, TY Ling, M Mori, WV Cardoso, M Morimoto
Proceedings of the National Academy of Sciences 2016
Exogenous Glutamine in Respiratory Diseases: Myth or Reality?
G Oliveira, M Abreu, P Pelosi, P Rocco
Nutrients 2016
The formation and function of tertiary lymphoid follicles in chronic pulmonary inflammation
K Yadava, P Bollyky, MA Lawson
Immunology 2016
The asthma–COPD overlap syndrome: do we really need another syndrome in the already complex matrix of airway disease?
K Kostikas, A Clemens, F Patalano
International journal of chronic obstructive pulmonary disease 2016
Role of nitro-oxidative stress in the pathogenesis of experimental rat periodontitis
BA Boșca, V Miclăuș, A Ilea, RS Câmpian, V Rus, F Ruxanda, C Rațiu, A Uifălean, AE Pârvu
Clujul Medical 2016
A Paradox: α-Klotho Levels and Smoking Intensity.
Verde Z, González-Moro JM, Chicharro LM, Reinoso-Barbero L, Bandrés F, Gómez-Gallego F, Santiago C
Lung 2016
The Pattern of Elastic Fiber Breakdown in Bleomycin-Induced Pulmonary Fibrosis May Reflect Microarchitectural Changes.
Liu X, Ma S, Turino G, Cantor J
Lung 2016

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Referenced in 1 patents
Mentioned in 1 LinkedIn forums
459 readers on Mendeley
See more details